Double or triple down: how AFT Pharmaceuticals plans to win in China
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ sharemarket rises with gentailers leading
Electricity gentailers pumped energy into the NZX.
NZ businessman Graeme Clegg remains detained in Vietnam
He's been diagnosed with cancer in his colon.
James Wallace is 'low risk, but not no risk' of reoffending
Why James Wallace remains under strict release conditions.
Active beats passive in tough times
Agile investing responds faster to market shocks and shifts.
